BioPharma Dive - Latest News

Bayer drug could ease side effects of common breast cancer treatment, detailed data show

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer application for approval.

Jun 3, 2025 - 17:35
 0
Bayer drug could ease side effects of common breast cancer treatment, detailed data show

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer application for approval.

Read More

Tags:

Previous Article

Regulatory tracker: AZ's Farxiga cleared for use in UK in broader kidney disease...

Next Article

Navy’s Phelan says DOGE’s cost cutting has saved $1B for service

Related Posts

FDA panel backs Darzalex for early stage multiple myeloma

FDA panel backs Darzalex for early stage multiple myeloma

May 21, 2025  0

FDA sets COVID vaccine formula as RFK Jr. narrows guidance for shots

FDA sets COVID vaccine formula as RFK Jr. narrows guida...

May 27, 2025  0

The transformative impact of integrated informatics platforms on biopharma R&D

The transformative impact of integrated informatics pla...

May 27, 2025  0